Skip to main content
SpringerLink
Log in

1-(o-Chlorophenyl)-1-(p-Chlorophenyl)-2,2-Dichloroethane (o,p’-DDD), an Adrenocorticolytic Agent

  • Chapter
Book cover Antineoplastic and Immunosuppressive Agents

  • 489 Accesses

Abstract

The compound 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane, best known by its trivial name o,p’-DDD, has been assigned the generic name Mitotane and is available in the United State under the trade name Lysodren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abelson, D., Bulaschenko, H., Trommer, P. R., Valdes-Dapena, A.: Malignant interstitial-cell tumor of the testis treated with o,p’-DDD. Metabolism 15, 242–256 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Azarnoff, D. L., Grady, H. J., Svoboda, D. J.: The effect of DDD on barbiturate and steroid induced hypnosis in the dog and rat. Biochem. Pharmacol. 15, 1985–1993 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Bergenstal, D. M., Hertz, R., Lipsett, M. B., Moy, R. H.: Chemotherapy of adrenocortical cancer with o,p’-DDD. Ann. int. Med. 53, 672–682 (1960).

    CAS  Google Scholar 

  • Bledsoe, T., Island, D. P., Key, R. L., Liddle, G. W.: An effect of o,p’-DDD on the extra adrenal metabolism of Cortisol in man. J. clin. Endocrinol. 24, 1303–1311 (1964).

    Article  CAS  Google Scholar 

  • Brown, J. H. U., Preedy, J. R. K., Brown, C. H., Hallman, B. L.: Action of an adrenocorticolytic drug in man. Lancet I, 1208–1209 (1959).

    Google Scholar 

  • Burstein, S., Klaiber, E. L.: Phenobarbital-induced increase in 6β-hydroxycortisol excretion: clue to its significance in human urine. J. clin. Endocrinol. 25, 293–296 (1965).

    Article  CAS  Google Scholar 

  • Cazorla,A., Moncloa, F.: Action of l,l,dichloro-2-p-chlorophenyl-ethane on dog adrenal cortex. Science 136, 47 (1962).

    Google Scholar 

  • Conney, A. H., Welch, R. W., Kttntzman, R.: Effects of pesticide on drug and steroid metabolism. Clin. Pharmacol. Ther. 8, 2–10 (1967).

    PubMed  CAS  Google Scholar 

  • Cope, C. L.: The case of the persistent pituitary. Brit. med. J. 2, 557–560 (1969).

    Article  Google Scholar 

  • Cueto, C., Brown, J. H. A.: Biological studies on an adrenocorticolytic agent and the isolation of the active components. Endocrinology 62, 334–339 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Danowski, T. S., Sarver, M. E., Moses, C., Bonessi, J. V.: o,p’-DDD therapy in Cushing’s syndrome and in obesity with cushingoid changes. Amer. J. Med. 87, 235–250 (1964).

    Google Scholar 

  • Datta, P. R.: In vivo detoxification of p,p’-DDT via pp’-DDE to ,p p’-DDA in rats. Indust. Med. 39, 190–194 (1970).

    Google Scholar 

  • Datta, P. R., Nelson, M. J.: pp’-DDT detoxication by isolated perfused rat liver and kidney. Indust. Med. 89, 195–198 (1970).

    Google Scholar 

  • Digiulio, W., Beierwaltes, W. H.: Tissue localization studies of a DDD analog. J. nucl. Med. 9, 634–637 (1968).

    PubMed  CAS  Google Scholar 

  • Finnegan, J. K., Haag, H. B., Larson, P. S.: Tissue distribution and elimination of DDD and DDT following oral administration to dogs and rats. Proc. Soc. exp. Biol. (N. Y.) 72, 357–360 (1949).

    CAS  Google Scholar 

  • Fisher, D. A., Panos, T. C., Melby, J. C.: Therapy of adrenocortical cancer with o,p’-DDD in two children. J. clin. Endocrinol. 23, 218–221 (1963).

    Google Scholar 

  • Fukushima, D. K., Bradlow, H. L., Hellman,L.: Effects of o,p’ DDD on Cortisol and 6-beta- hydroxycortisol secretion and metabolism in man. J. clin. Endocrinol. 32, 192–200 (1971).

    Article  CAS  Google Scholar 

  • Grady, H. J., Azarnoff, D. L., Creager, R., Huffman, D. H., Nichols, J.: Specificity of enzyme inhibition by DDD. Proc. Soc. exp. Biol. (N.Y.) 119, 238–241 (1965).

    CAS  Google Scholar 

  • Greene, F. E., Stripp, B., Gillette, J. R.: The effect of carbon tetrachloride on heme components and ethylmorphine metabolism in rat liver microsomes. Biochem. Pharmacol. 18, 1631–1533 (1969).

    Google Scholar 

  • Hart, M. M., Reagan, R. L., Adamson, R. H.: The effect of isomers of DDD on the ACTH induced steroid output, histology and ultrastructure of the dog adrenal cortex. Toxicol. Appl. Pharmacol. 24, 101–113 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Hart, M. M., Straw, J. A.: Effect of l-(o-chlorophenyl)-l-(p-chlorophenyl)-2,2-dichloroethane on adrenocorticotropic hormone-induced steroidogenesis in various preparations in vitro of dog adrenal cortex. Biochem. Pharmacol. 20, 1679–1688 (1971a).

    Article  CAS  Google Scholar 

  • Hart, M. M., Straw, J. A.: Effect of l-(o-chlorophenyl)-l-(p-chlorophenyl)-2,2-dichloroethane in vivo on baseline and adrenocorticotropic hormone-induced steroid production in dog adrenal slices. Biochem. Pharmacol. 20, 1689–1691 (1971b).

    Article  CAS  Google Scholar 

  • Hart, M. M., Straw, J. A.: Studies on the site of action of o,p’-DDD in the dog adrenal cortex. I. Inhibition of ACTH-mediated pregnenolone synthesis. Steroids 17, 559–574 (1971c).

    Article  PubMed  CAS  Google Scholar 

  • Hart, M. M., Straw, J. A.: Effects of l-(o-chlorophenyl)-l-(p-chlorophenyl)-2,2-dichloroethane and puromycin on adrenocorticotropic hormone-induced steroidogenesis and on amino acid incorporation in slices of dog adrenal cortex. Biochem. Pharmacol. 20, 257–263 (1971 d).

    Google Scholar 

  • Hart, M. M., Swackhamer, E. S., Straw, J. A.: Studies on the site of action of o,p’-DDD in the dog adrenal cortex. II. TPNH and corticosteroid precursor-stimulation of o,p’-DDD inhibited steroidogenesis. Steroids 17, 575–586 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Hutter, A. M., Kayhoe, D. E.: Adrenal cortical carcinoma — Clinical features of 138 patients. Amer. J. Med. 41, 572–580 (1966a).

    Article  PubMed  Google Scholar 

  • Hutter, A. M., Kayhoe, D. E.: Adrenal cortical carcinoma — Results of treatment with o,p’- DDD in 138 patients. Amer. J. Med. 41, 581–592 (1966b).

    Article  PubMed  Google Scholar 

  • Kaminsky, N., Luse, S., Hartroft, P.: Ultrastructure of adrenal cortex of the dog during treatment with DDD. J. nat. Cancer Inst. 29, 127–159 (1962).

    PubMed  CAS  Google Scholar 

  • Kupfer, D., Peets, L.: The effects of o,p’-DDD on Cortisol and hexobarbital metabolism. Biochem. Pharmacol. 15, 573–581 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Lipsett, M. B., Kirschner, M. A., Wilson, H., Bardin, C. W.: Malignant lipid cell tumor of the ovary. Clinical, biochemical and etiologic considerations. J. clin. Endocrinol. 30, 336–344 (1970).

    Article  CAS  Google Scholar 

  • Lubitz, J.A., Freeman, L., Okun, R.: Mitotane use in inoperable adrenal cortical carcinoma. J. Amer. med. Ass. 233, 1109–1112 (1973).

    Article  Google Scholar 

  • Marshall, J. A., Tompkins, L.S.: Effect of o,p’-DDD and similar compounds on thyroxine binding globulin. J. clin. Endocrinol. 24, 386–392 (1968).

    Article  Google Scholar 

  • Martz, F., Straw, J. A.: Effects of Mitotane (o,p’-DDD) on hepatic drug metabolism in dogs. Fed. Proc. 81, 581 (1972).

    Google Scholar 

  • Martz, F., Straw, J. A.: Mitotane decreases adrenal cortical heme and P450. F.d. Proc. 32 (3), 734 (1973).

    Google Scholar 

  • Molnar, G. D., Mattox, V. R., Bahn, R. C.: Clinical and therapeutic observations in adrenal cancer. A report on 7 patients treated with o,p’-DDD. Cancer 16, 259–268 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Moy, R. H.: Studies of the pharmacology of o,p’-DDD in man. J. Lab. clin. Med. 58, 296–304 (1961).

    PubMed  CAS  Google Scholar 

  • Nelson, A. A., Woodward, G.: Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(para-chlorophenyl)-l,l-dicMoroethane (DDD or TDE). Arch. Path. 48, 387–394 (1949).

    PubMed  CAS  Google Scholar 

  • Nichols, J.: Studies on an adrenal cortical inhibitor. In: Moon, H. D. (Ed.): The adrenal cortex. Int. Acad, of Path. Monograph. New York: Harper and Brothers 1961.

    Google Scholar 

  • Nichols, J., Green, H. D.: Effect of DDD treatment on metabolic response of dogs to ACTH injection. Amer. J. Physiol. 176, 374–376 (1954).

    PubMed  CAS  Google Scholar 

  • Nichols, J., Hennigar, G.: Studies on DDD, 2,2-bis-(parachlorophenyl)-1,1 -dichloroethane. Exp. Med. Surg. 15, 310–316 (1957).

    PubMed  CAS  Google Scholar 

  • Nichols, J., Prestley, W. F., Nichols, F.: Effects of m,p’-DDD in a case of adrenal corticol carcinoma. Curr. Ther. Res. 3, 266–271 (1961).

    PubMed  CAS  Google Scholar 

  • Sakauchi, N., Kumaoka, S., Naruke, T., Abe, O., Kusama, M., Takatani, O.: A case of adrenocortical cancer treated with o,p’-DDD. Endocrinology 16, 287–290 (1969).

    Google Scholar 

  • Southren, A. L., Tochimoto, S., Strom, L., Ratuschni, A., Ross, R., Gordon, G.: Remission in Cushing’s syndrome with o,p’-DDD. J. clin. Endocrinol. 26, 268–278 (1966).

    Article  CAS  Google Scholar 

  • Southren, A. L., Weisenfeld, S., Laufer, A., Goldner, M.G.: Effect of o,p ’-DDD in a patient with Cushing’s syndrome. J. clin. Endocrinol. 21, 201–208 (1961).

    Article  CAS  Google Scholar 

  • Straw, J. A., Waters, I. W., Fregly, M. J.: Effect of o,p’-DDD on hepatic metabolism of pentobarbital in rats. Proc. Soc. exp. Biol. 118, 391–394 (1965).

    PubMed  CAS  Google Scholar 

  • Tamoney, H. J., Jr., Noriega,A.: Malignant interstitial cell tumor of the testis. Cancer 24, 547–551 (1969).

    Google Scholar 

  • Temple, T. E., Jones, D. J., Liddle, G. W., Dexter, R. N.: Treatment of Cushing’s disease. Correction of hypercortisolism by o,p’-DDD without induction of aldosterone deficiency. N. Engl. J. Med. 281, 801–805 (1969).

    Google Scholar 

  • Wallace, E. Z., Silverstein, J. N., Villadolid, L. S., Weisenfeld, S.: Cushing’s syndrome due to adrenocortical hyperplasia. N. Engl. J. Med. 265, 1088–1093 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Wedemeyer, G.: Dechlorination of l,l,l-trichloro-2,2-bis(p-chlorophenyl)ethane by Aerobacter aerogenes. Appl. Microbiol. 15, 569–574 (1967).

    PubMed  CAS  Google Scholar 

  • Weisenpeld, S., Hecht, A., Leichter, D., Goldner, M.: o,p’-DDD in the treatment of advanced mammary carcinoma. Cancer 17, 1258–1266 (1964).

    Google Scholar 

  • Zimmerman, B., Blooh, H. L., Williams, W. L., Hitchcock, C. R., Hoelscher,B.: The effects of DDD [l,l-dichloro-2,2-bis(p-chlorophenyl)ethane] on the human adrenal. Cancer 9, 940–948 (1956).

    Article  Google Scholar 

Download references

Authors
  1. James A. Straw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael M. Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, Yale University School of Medicine, 06510, New Haven, Connecticut, USA

    Alan C. Sartorelli (Professor) (Professor)

  2. Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, 20014, Bethesda, Maryland, USA

    David G. Johns M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1975 springer-Verlag Berlin-Heidelberg

About this chapter

Cite this chapter

Straw, J.A., Hart, M.M. (1975). 1-(o-Chlorophenyl)-1-(p-Chlorophenyl)-2,2-Dichloroethane (o,p’-DDD), an Adrenocorticolytic Agent. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-65806-8_45

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-65808-2

  • Online ISBN: 978-3-642-65806-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation